SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-000831
Filing Date
2017-02-22
Accepted
2017-02-22 16:33:30
Documents
65
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2230972z10-k.htm 10-K 1329617
2 EX-23.1 a2230972zex-23_1.htm EX-23.1 4822
3 EX-31.1 a2230972zex-31_1.htm EX-31.1 7901
4 EX-32.1 a2230972zex-32_1.htm EX-32.1 4051
11 G785806.JPG g785806.jpg GRAPHIC 46998
  Complete submission text file 0001047469-17-000831.txt   7037956

Data Files

Seq Description Document Type Size
5 EX-101.INS espr-20161231.xml EX-101.INS 1890246
6 EX-101.SCH espr-20161231.xsd EX-101.SCH 39319
7 EX-101.CAL espr-20161231_cal.xml EX-101.CAL 56402
8 EX-101.LAB espr-20161231_lab.xml EX-101.LAB 449203
9 EX-101.PRE espr-20161231_pre.xml EX-101.PRE 305463
10 EX-101.DEF espr-20161231_def.xml EX-101.DEF 154849
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 17628895
SIC: 2834 Pharmaceutical Preparations